Price hikes, a strategic retreat and 1 big new approval has shaken up the rankings of the 20 most expensive drugs on the planet
It’s been just 4 months since GoodRx released its newly expanded list of the 20 most expensive drugs on the planet, and there have already been some big changes.
Thanks to drugmakers’ ability to set their US price at what the market will bear when they have a monopoly, no matter how controversial, several of the most prominent companies on the list — a group that covers Big Pharma, biotech and some financially stressed specialists — managed to move up on the ranking based on a higher wholesale price, according to a list maintained by GoodRx.
We’ll note quickly that wholesale monthly costs are the ticket price used to dicker with drug payers, and don’t represent the average cost. They are also the only prices that are posted.
Basic subscription required
Unlock this story instantly and join 58,000+ biopharma pros reading Endpoints daily — and it's free.